IRIS
ALAFACI, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 689
EU - Europa 585
AS - Asia 146
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.423
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 687
SE - Svezia 165
IE - Irlanda 162
CN - Cina 121
GB - Regno Unito 58
IT - Italia 57
UA - Ucraina 39
DE - Germania 31
PL - Polonia 26
FI - Finlandia 20
BE - Belgio 18
SG - Singapore 11
FR - Francia 6
IN - India 6
VN - Vietnam 4
CA - Canada 2
JP - Giappone 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
IR - Iran 1
NO - Norvegia 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 1.423
Salva come PNG Salva come JPEG
Città #
Dublin 162
Chandler 152
Nyköping 97
Jacksonville 82
Ann Arbor 67
Ashburn 39
Beijing 39
New York 32
Messina 29
Lancaster 28
Warsaw 26
Dearborn 23
Cambridge 20
Medford 20
Princeton 20
Brussels 18
Woodbridge 18
Boardman 14
Des Moines 14
Jinan 13
San Mateo 9
Hebei 8
Leawood 8
Nanjing 6
Singapore 6
Tianjin 6
Wilmington 6
Zhengzhou 6
Changsha 5
Dong Ket 4
Ningbo 4
Shenyang 4
Aci Catena 3
Hangzhou 3
London 3
Los Angeles 3
Milan 3
Nanchang 3
Rome 3
Taizhou 3
Augusta 2
Brooklyn 2
Carlentini 2
Fuzhou 2
Grammichele 2
Haikou 2
Hefei 2
Hyderabad 2
Jiaxing 2
Norwalk 2
Pune 2
Tappahannock 2
Ardabil 1
Bangalore 1
Birmingham 1
Chengdu 1
Copenhagen 1
Enna 1
Frankfurt am Main 1
Fremont 1
Guangzhou 1
Helsinki 1
Houston 1
Johannesburg 1
Katsushika 1
Lanzhou 1
Las Vegas 1
Monmouth Junction 1
Olomouc 1
Oslo 1
Ottawa 1
Palazzolo Acreide 1
Paris 1
San Francisco 1
Scicli 1
Seattle 1
Stockholm 1
Taby 1
Taiyuan 1
Toronto 1
Washington 1
Totale 1.062
Salva come PNG Salva come JPEG
Nome #
Prognostic value of methlylenetetrahydrofolate reductase (MTHFR), thymidylate synthase (TS) promoter, and p53 codon 72 variants and survival in advanced non-small cell lung cancer (NSCLC). 117
Incidence and Outcomes of Bone Metastases. Evaluation of BTAs Therapy, Pain Relief and Quality of Life: Experience from a Single Cancer Center 111
Intracranial venous sinus thrombosis as unusual presentation of Bing-Neel syndrome: case illustration. 87
Phase II study of gemcitabine and cisplatin in patients with advanced or metastatic bladder cancer: long-term follow-up of a 3-week regimen 82
zd1839"iressa" in heavily pretreated patients with advaned/metastatic non-small cell lung cancer(NSCLC):assessment of tolerability and the clinical benefit 80
Epirubucin (EPI) and Paclitaxel (TAX) in advanced breast cancer.a phase II studyi 80
Second line chemoterapy in patients with metastatic colorectal cancer(MCRC):our experience 77
Trattamento endoscopico scleroterapico nelle neoplasie sanguinanti del tratto digestivo. 75
[Serum levels of copper and zinc in patients with lung cancer] 72
ZD 1839 IRESSA IN HEAVILY PRETREATED PATIENTS WITH ADVANCED/METASTATIC NON SMALL CELL LUNG CANCER:ASSESSMENT OF TOLERABILITY AND CLINICAL BENEFIT 70
VP16, epirubicin and procarbazine in the treatment of advanced non-small-cell lung cancer. 67
Safety of Capecitabine plus Bevacizumab in heavily treated patients with metastatic colorectal cancer (MCRC) 66
Gemcitabine (GEM) and cisplatin (CIS) in advanced/metastatic transitional cell carcinoma (TCC) of bladder:phase II study 66
I Tumori del coloretto. La chemioterapia della fase avanzata. 65
Gefitinib versus Erlotinib treatment in Non Small Cell Lung Cancer (NSCLC): comparison of two clinical experiences. 65
gemcitabine and pegylated liposomial doxorubicin in recurrent epithelial ovarian cancer (REOC).Preliminary report a phase II study 63
Treatment of advanced and/or metastatic epidermoid carcinoma of the head and neck: an effective combination chemotherapy with bleomycin, methotrexate and ftorafur. 61
A rare case of solitary brain Langerhans cell histiocytosis with intratumoral hemorrhage in a patient affected by Turner syndrome 61
Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma. 58
RANDOMISED PHASE II TERTIARY CHEMOPREVENTION TRIAL FOR COLORECTAL ADENOMA IN 24 PATIENTS WITH COLORECTAL CANCER TREATED WITH CELECOXIB 44
Totale 1.467
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.439
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020182 23 9 5 10 1 24 25 22 2 22 34 5
2020/2021256 23 5 58 16 10 16 8 9 36 29 32 14
2021/2022167 3 32 2 10 8 0 16 8 2 22 19 45
2022/2023525 43 62 20 54 41 44 7 36 195 1 14 8
2023/2024128 11 13 6 23 7 56 0 1 1 3 0 7
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 1.467